Neuroprotective effect of 5-HT(1A) receptor agonist, Bayx3702, demonstrated in vitro and in vivo

European Journal of Pharmacology

Volumn 359, Issue 2-3, 1998, Pages 251-260

  Semkova, Irina ^a   Wolz, Philipp ^b   Krieglstein, Josef ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Bayx3702; Excitotoxicity; Glutamate; Hippocampal cell; Permanent focal ischemia; Rat

Indexed keywords

GLUTAMIC ACID; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; REPINOTAN; SEROTONIN 1 AGONIST; SEROTONIN 1A RECEPTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN ISCHEMIA; BRAIN TISSUE; CELL DAMAGE; CELL STRUCTURE; CONTROLLED STUDY; HIPPOCAMPUS; IN VITRO STUDY; INTRAVENOUS DRUG ADMINISTRATION; NERVE CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BENZOPYRANS; BRAIN; BRAIN ISCHEMIA; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL INFARCTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; HIPPOCAMPUS; MALE; NEURONS; RATS; RATS, INBRED F344; RATS, LONG-EVANS; SEROTONIN AGONISTS; THIAZOLES;

EID: 0032561474     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00634-7     Document Type: Article

References (51)

1. 1A receptor inhibits apoptosis induced by serum deprivation in cultured neurons from chick embryo. Brain Res. 777:1997;179-186.
2. B receptors to the same channel in hippocampus. Science. 234:1986;1261-1265.
3. 1A receptors mediate opposing responses on membrane excitability in rat association cortex. Neuroscience. 40:1991;399-412.
4. Ankarcrona M., Dypbukt J.M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S.A., Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
5. Azmitia E.C., Dolan K., Whitaker-Azmitia P.M. S-100β but not NGF, EGF, insulin, or calmodulin is a serotonergic growth factor. Brain Res. 516:1990;354-356.
6. 1A receptor in primate brain neurons and glial cells. Neuropsychopharmacology. 14:1996;35-46.
7. Barger S.W., van Eldik L.J., Mattson M.P. S-100β protects hippocampal neurons from damage induced by glucose deprivation. Brain Res. 677:1995;167-170.
8. Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentration of glutamate and aspartate in rat hippocampus during cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43:1984;1369-1974.
9. 1A agonists: a new therapeutic principle for stroke treatment. Stroke. 21(Suppl. IV):1990;161-163.
10. 1A agonists on hippocampal damage after transient forebrain ischemia in the Mongolian gerbil. Stroke. 21(Suppl. IV):1990;164-166.
11. 1A receptors on neurones of the rat midbrain tectum. Brain Res. 556:1991;259-266.
12. 1A binding in rat brain - a combined in situ hybridization/in vitro receptor autoradiographic study. Brain Res. 561:1991;51-60.
13. + currents in rat serotonergic neurones. J. Physiol. 496:1996;120-137.
14. Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-643.
15. Davies M.F., Deisz R.A., Prince D.A., Peroutka S.J. Two distinct effects of 5-hydrohytryptamine on single cortical neurons. Brain Res. 423:1987;247-352.
16. Desphande J.K., Siesjö B.K., Wieloch T. Calcium accumulation and neuronal damage in the rat hippocampus following cerebral ischemia. J. Cereb. Blood Flow Metab. 7:1987;89-95.
17. 1A receptor agonists: recent developments and controversial issues. Psychopharmacology. 121:1995;1-26.
18. de Vry J., Dietrich H., Glaser T., Heine H.-G., Horvath E., Jork R., Maertins T., Mauler F., Opitz W., Scherling D., Schone-Loop R., Schwarz T. Bay×3702. Drugs Future. 22:1997;341-349.
19. Donato R. Perspective in S-100 protein biology. Cell Calcium. 12:1991;713-726.
20. 1A affinity and hypotensive activity. Eur. J. Pharmacol. 112:1985;363-370.
21. 2+ concentration can be useful tool to predict neuronal damage and neuroprotective properties of drugs. Brain Res. 732:1996;87-94.
22. Foehring R.C. Serotonin modulates N- and P-type calcium currents in neocortical pyramidal neurons via a membrane-deliminited pathway. J. Neurophysiol. 75:1996;648-659.
23. 1-adrenoceptor binding sites. Naunyn-Schmiedeberg's Arch. Pharmacol. 336:1987;597-607.
24. Haring J.H., Hagan A., Olson J., Rodgers B. Hippocampal serotonin levels influence the expression of S-100β detected by immunocytochemistry. Brain Res. 631:1993;119-123.
25. 1A receptor agonist BAY×3702 in a rat model of permanent focal cerebral ischemia and traumatic brain injury. Soc. Neurosci. Abstr. 23:1997;1923.
26. Humphrey P.P.A., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 414:1993;233-236.
27. Koh J.I., Choi D.W. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase. J. Neurosci. 8:1988;2153-2163.
28. Kozuka M., Iwata N. Changes in levels of monoamines and their metabolites in incompletely ischemic brains of spontaneously hypertensive rats. Neurochem. Res. 20:1995;1429-1435.
29. Krieglstein, J., 1996. Pharmacology of cerebral ischemia 1996. Medpharm Scientific Publishers, Stuttgart.
30. Liu J.P., Lauder J.M. S-100β and insulin-like growth factor-II differentially regulate growth of developing serotonin and dopamine neurons in vitro. J. Neurosci. Res. 33:1992;248-256.
31. 2 receptors. Eur. J. Pharmacol. 145:1988;31-38.
32. 1A receptor mRNA in rat forebrain and cerebellum. Dev. Brain Res. 80:1994;149-157.
33. Murase K., Randic M., Shirasaki T., Nakagawa T., Akaike N. Serotonin suppresses N-methyl-D-aspartate responses in acutely isolated spinal dorsal horn of the rat. Brain Res. 525:1990;84-91.
34. Nakata N., Kogure K., Itoyama Y., Kato H., Ikeda Y., Tanaka Y., Izumi J., Suda H. Role of hippocampal serotonergic neurons in ischemic neuronal death. Behav. Brain Res. 83:1997;217-220.
35. 1A agonist CM57493 on infarct area, infarct volume and hippocampal neuronal damage after focal and global cerebral ischemia in mice and rats. In: Krieglstein, J., Oberpichler, H. (Eds.), Pharmacology of Cerebral Ischemia 1990. Wissenschaftliche Verlagsgesellschaft Stuttgart, pp. 493-497.
36. Pazos A., Palacios M. Quantitative autoradiographic maping of serotonin receptors in rat brain: I. Serotonin-1 receptors. Brain Res. 346:1985;205-230.
37. 2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J. Neurosci. 11:1991;3594-3609.
38. 1A receptor agonists, 8-OH-DPAT, buspirone and flesinoxan, upon brain damage induced by transient global cerebral ischemia in gerbils. Arch. Int. Pharmacodyn. Ther. 329:1995;347-359.
39. Prehn J.H.M., Welsch M., Backhauß C., Nuglisch J., Ausmeier F., Karkoutly C., Krieglstein J. Effects of serotoninergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemia. Brain Res. 630:1993;10-20.
40. Rami A., Krieglstein J. Brain damage caused by ischemia: pathophysiological and pharmacological aspects. Dementia. 4:1993;21-31.
41. 1A receptor agonists on the glutamate-induced rise in cytosolic calcium concentration as well as on calcium and potassium currents in hippocampal neurons. In: Krieglstein, J., Oberpichler-Schwenk, H. (Eds.), Pharmacology of Cerebral Ischemia 1994. Medpharm Scientific Publishers, Stuttgart, pp. 89-94.
42. Segal M. The action of serotonin in rat hippocampal slice preparation. J. Physiol. 303:1980;423-439.
43. 2 receptor antagonists. Eur. J. Pharmacol. 229:1992;21-29.
44. Siesjö B.K., Bengtsson F. Calcium fluxes, calcium antagonists and calcium related pathology in brain ischemia, hypoglycemia and spreading depression - a unifying hypothesis. J. Cereb. Blood Flow Metab. 9:1989;127-140.
45. Simon R.P., Swans J.H., Griffith T., Meldrum B.S. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science. 226:1984;850-852.
46. Tamura A., Graham D.I., McCulloch J., Teasdale G.M. Focal cerebral ischemia in the rat: 1. Description of the technique and early neuropathological consequences following middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1:1981;53-60.
47. Ueda S., Hou X.P., Whitaker-Azmitia P.M., Azmitia E.C. Neuro-glial neurotrophic interaction in the S-100β retarded mutant mouse (Polydactyly Nagoya): II. Co-cultures study. Brain Res. 633:1994;284-288.
48. Whitaker-Azmitia P.M., Azmitia E.C. Autoregulation of fetal serotonergic neuronal development: role of high-affinity serotonin receptors. Neurosci. Lett. 67:1986;307-311.
49. 1A receptors releases the serotonergic growth factor, protein S-100 and alters glial morpholigy. Brain Res. 528:1990;155-158.
50. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin 1A, 1C and 2 receptor subtype mRNA in rat brain. J. Comp. Neurol. 351:1995;357-373.
51. 1A receptors mediate neurotrophic effect of serotonin on developing dentate granule cells. Dev. Brain Res. 98:1995;185-190.